Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This pilot study found that using skin patting and iontophoresis to deliver a 6% dutasteride gel led to significant improvements in hair density and shaft diameter in men and postmenopausal women with treatment-resistant androgenetic alopecia, with no reported adverse events.

This study found that OZiva+ advanced hair growth serum significantly increased hair follicle length and showed no irritation, indicating it may be a safer alternative to traditional hair loss treatments like minoxidil.

In this observational study, researchers found that acute telogen effluvium, a form of temporary hair loss, occurred in 80 patients following COVID-19 infection, with 70 showing a significant decrease in hair density and trichoscopic signs like peripilar sign and yellow dots.

This study observed that LED therapy improved hair regrowth and reduced hair loss in patients with post-COVID telogen effluvium, with or without androgenetic alopecia, compared to those who did not receive LED treatment.

This study found that low ferritin levels are associated with higher telogen ratios in women with diffuse hair loss, suggesting an important role of ferritin in telogen effluvium diagnosis.

In a study of 50 healthy adults, Keshohills hair oil was shown to be effective in reducing hair loss and treating seborrheic dermatitis.

This study observed that patients who received Favipiravir treatment after having COVID-19 had lower positive pull test scores for telogen effluvium hair loss compared to those who did not, suggesting that Favipiravir may not influence the development of telogen effluvium.

This case study reports a patient with ACTH-driven cortisol secretion 14 years after adrenalectomy, suggesting possible residual adrenal tissue or extra-adrenal steroid synthesis, challenging the need for lifelong steroid replacement.

This review discusses telogen effluvium, a common form of hair loss, and reports no new clinical results; the authors outline possible causes, typical prognosis, and management strategies.

This chapter reviews types and causes of hair loss in children and suggests a diagnostic approach for identifying and treating this condition, but it reports no new clinical results.

Postpartum hair loss usually stops within 4-6 months.

This study concluded that a new model of reconstructed human epidermis using keratinocytes from plucked hair follicles offers a less-invasive alternative to conventional skin-derived models for skin research.

This study reported that administering a supraphysiological dose of testosterone for one year resulted in minor cognitive benefits and decreased depressive symptoms in older hypogonadal men, but major cognitive improvements were not observed.

This study assessed the effects of a formulation containing millet extract, wheat germ oil, L-cystine, and calcium pantothenate on women with telogen effluvium using Digital Phototrichogram, but it reports no new results.

In this study conducted among students aged 15-17 at SMAN 7 Tangerang Selatan, researchers found no significant link between nutritional status and the occurrence of telogen effluvium, suggesting other factors like hormonal imbalances or psychological stress may be more influential.

This study found that men with androgenetic alopecia had significantly higher rates of dry eye symptoms and meibomian gland dysfunction compared to healthy controls, suggesting a potential link between the condition and these ocular issues.

This study found that SULT1A1 enzyme activity, crucial for activating minoxidil, is significantly lower in eyebrow and eyelash follicles compared to scalp follicles, suggesting that additional sulfotransferase supplementation might enhance minoxidil-based hair growth treatments for these areas.

This study found that DR SKS Hair Growth Booster Serum significantly reduced hair fall and improved hair density in patients with androgenic alopecia over six months, with high patient satisfaction and no major adverse events reported.

In this study, minoxidil combined with PRP was found to effectively increase hair density in women with female pattern hair loss, but showed no superiority over minoxidil alone. No major side effects were reported.

This case report describes a 19-year-old woman with systemic lupus erythematosus and telogen effluvium, who experienced new hair growth and increased hair density after 90 days of treatment with 2% topical minoxidil and oral keratin-based antioxidants.

In this study, hair tonic containing 15% patchouli leaf extract showed the greatest hair growth in rabbits, with higher concentrations leading to faster regrowth.

This article reviews anagen effluvium, a type of non-scarring alopecia that affects both men and women, often induced by chemotherapy or radiation, and discusses diagnostic approaches but reports no new clinical findings.

This study found that non-scarring acquired alopecias were the most common hair and scalp diseases among children visiting a pediatric dermatology outpatient clinic.

In this case report, a 17-year-old with systemic lupus erythematosus showed improvement in erythema multiforme-like lesions after treatment with methylprednisolone.

This study found that standard decontamination procedures may not fully remove external contamination in post mortem hair specimens, complicating the interpretation of drug detection in such samples.

In this study, PRP therapy initially improved hair density in androgenetic alopecia, but effects decreased over time, suggesting additional treatment may be needed for sustained results.

This study observed that while platelet-rich plasma showed positive short-term effects on hair density in individuals with androgenic alopecia, its effectiveness declined after four months, suggesting possible need for additional treatment.

A simple method using the wash test and dermatoscopy can help differentiate between two hair loss conditions, androgenetic alopecia and chronic telogen effluvium.

A simple wash test can help differentiate between two types of hair loss, and dermatoscopy should be used for further clarification.

A simple method using the wash test and dermatoscopy can help differentiate between two hair loss conditions, androgenetic alopecia and chronic telogen effluvium.